US Broker Ratings

Keros Therapeutics, Inc. (KROS) Stock Analysis: Exploring a Potential 103% Upside in Biotech

Keros Therapeutics, Inc. (NASDAQ: KROS) is a promising player in the biotechnology sector focused on developing innovative treatments for complex blood disorders and cardiovascular diseases. With..

Valneva SE (VALN): Investor Outlook with a 105% Potential Upside in the Biotech Sector

Valneva SE (VALN), a French specialty vaccine company, is attracting significant attention in the biotechnology sector, primarily due to its promising potential upside of 105.64%. With..

Inventiva S.A. (IVA): Uncovering a Potential 233.95% Upside in the Biotechnology Sector

Investors eyeing the biotechnology sector may find Inventiva S.A. (IVA) to be a compelling opportunity, especially considering its notable potential upside of 233.95%. This French biopharmaceutical..

Savara, Inc. (SVRA) Stock Analysis: Unpacking a 201.82% Potential Upside in the Biotech Sector

Savara, Inc. (SVRA), a clinical-stage biopharmaceutical company, has captured the attention of investors with its focus on rare respiratory diseases. With a market capitalization of $404.44..

Capricor Therapeutics, Inc. (CAPR): Investor Outlook Highlights an Impressive 383% Potential Upside

Capricor Therapeutics, Inc. (NASDAQ: CAPR) is capturing attention in the biotechnology sector, not only for its innovative approach to treating diseases with unmet medical needs but..

MeiraGTx Holdings plc (MGTX) Stock Analysis: Exploring a 219% Potential Upside in Biotech Innovation

MeiraGTx Holdings plc (NASDAQ: MGTX) has been capturing investor attention with its robust pipeline in the biotechnology sector. Specializing in genetic medicines, the company is making..

MBX Biosciences, Inc. (MBX) Investor Outlook: Exploring 206.68% Potential Upside in Biotech Innovation

In the dynamic world of biotechnology, MBX Biosciences, Inc. (MBX) stands out as a promising player with a focus on precision peptide therapies aimed at treating..

Niagen Bioscience, Inc. (NAGE) Stock Analysis: A 44% Upside Potential in the Biotech Space

Niagen Bioscience, Inc. (NAGE) is a rising star in the biotechnology sector, carving a niche for itself in the healthcare industry with a focus on developing..

Semler Scientific, Inc. (SMLR) Stock Analysis: Navigating a Healthcare Device Firm with a Unique Market Position

For investors eyeing the healthcare sector, Semler Scientific, Inc. (NASDAQ: SMLR) presents an intriguing proposition. Headquartered in Santa Clara, California, this company operates within the medical..

Personalis, Inc. (PSNL): Analyst Ratings Signal Strong Buy with 8% Upside Potential

Personalis, Inc. (NASDAQ: PSNL) is making waves in the healthcare sector, particularly within the diagnostics and research industry. Headquartered in Fremont, California, Personalis is carving out..

AbCellera Biologics Inc. (ABCL): Investor Outlook with a 116% Potential Upside

AbCellera Biologics Inc. (NASDAQ: ABCL) stands as a noteworthy player in the biotechnology sector, specializing in the discovery and development of antibody-based medicines. Headquartered in Vancouver,..

Standard BioTools Inc. (LAB) Stock Analysis: Navigating a 90% Potential Upside in the Medical Devices Sector

In the ever-evolving world of medical devices, Standard BioTools Inc. (NASDAQ: LAB) stands out with its intriguing potential for investors. With a market cap of $451.55..

Abivax SA (ABVX) Investor Outlook: Analyzing the 254% Potential Upside

For investors with an appetite for growth in the biotechnology sector, Abivax SA (ABVX) presents a compelling opportunity. With its focus on harnessing the body’s regulatory..

Celcuity Inc. (CELC) Investor Outlook: Exploring a Potential 108.83% Upside in Biotechnology

As an emerging leader in the biotechnology sector, Celcuity Inc. (NASDAQ: CELC) is capturing investor attention with its innovative approach to cancer treatment. The company, headquartered..

Definitive Healthcare Corp. (DH) Stock Analysis: Navigating the Healthcare Information Landscape

Definitive Healthcare Corp. (NASDAQ: DH) operates within the dynamic healthcare sector, specifically in the health information services industry. Standing at a market capitalization of $431.51 million,..

Oric Pharmaceuticals, Inc. (ORIC) Stock Analysis: A Biotech with 69.66% Upside Potential

Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) stands out in the biotech sector, attracting investor interest with an impressive potential upside of 69.66%. This clinical-stage biopharmaceutical company is..

Kura Oncology, Inc. (KURA) Investor Outlook: Exploring a Potential 289.81% Upside

Kura Oncology, Inc. (NASDAQ: KURA), a clinical-stage biopharmaceutical company based in San Diego, California, is capturing investor attention with its innovative approach to cancer treatment and..

STAAR Surgical Company (STAA) Stock Analysis: Evaluating the 10.60% Potential Upside Amidst Market Challenges

STAAR Surgical Company (NASDAQ: STAA), an innovator in the healthcare sector, particularly in medical instruments and supplies, is attracting attention with its advanced implantable lens technology...

Mind Medicine (MindMed) Inc. (MNMD) Investor Outlook: Potential Upside of 175.90% Amid Strong Buy Ratings

Mind Medicine (MindMed) Inc. (MNMD), a burgeoning name in the biotechnology sector, is capturing the attention of investors with its promising pipeline and impressive potential upside...

CorMedix Inc. (CRMD) Stock Analysis: Biotech’s Hidden Gem with 71.64% Potential Upside

Investors with an eye on the healthcare sector have likely come across CorMedix Inc. (NASDAQ: CRMD), a promising player in the biotechnology industry. With a market..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds